Skip to main content
OpenTrials
Completed

NCT Number: NCT03295630

Validity of an Actigraph Accelerometer Following Critical Illness

This study will determine whether an Actigraph GT3X accelerometer can identify body position and quantify step count in a ward based population recovering from critical illness.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hull and East Yorkshire Hospitals NHS Trust

Hull, East Yorkshire, HU3 2JZ, United Kingdom

About this study

Ward based patients recovering from critical illness who satisfy the inclusion criteria will have an Actigraph GT3X accelerometer positioned on the thigh and ankle of the non dominant leg. These will be used as an objective method of identifying adoption of lying, sitting and standing postures and quantification of step count. Both placement sites will be investigated in isolation. A further analysis will be undertaken to determine whether combining data from both placement sites (ankle and thigh) is superior in identification of lying, sitting and standing postures compared to an isolated single site. Accelerometer data will be compared against direct observation as the criterion measure.

Patients will undertake a semi-structured movement protocol consisting of typical activities undertaken by this population. These include lying in bed, transferring over the side of the bed, sit to stand postural transfers (and the reverse), sitting in a chair and walking. Observation periods will not exceed 3 hours. During this time all aspects of the movement protocol will be completed.

The data from this study will be analysed to determine the validity of the Actigraph GT3X in identification of body position and quantification of step count using the placement sites described above.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

1 18 years of age or above.

  • Ventilated in excess of 48 hours during admission in the Intensive Care Unit (ICU).
  • Currently resident on a hospital ward (secondary care) following step down from ICU
  • Able to undertake all postural transfers independently or with minimal assistance (one person only).
  • Able to mobilise short distances, either independently or with assistance from a walking aid or one person.
  • Willing to permit application of two Actigraph GT3X accelerometers Each device weighs 27g with dimensions of 3.8cm x 3.7cm x 1.8cm.
  • Willing to consent to a period of direct observation for a length of time not exceeding three hours.

Exclusion criteria

  • Unable to provide informed written consent themselves
  • Unwilling to consent to a period of observation not exceeding three hours.
  • Unable to make an informed decision about participation or demonstrating an inability to interpret information or follow study instructions
  • Significant neurological or coordination impairment
  • Unable to speak or understand English.
  • Clostridium Difficile/ similar infection or unmanaged urinary incontinence.
  • Evidence/ diagnosis of peripheral vascular disease.
  • Lower limb amputation
  • Polytrauma which prevents the adoption or normal lying, sitting or standing postures, or placement of the accelerometers

Treatment and study plan

Accelerometer

Device

Participants will perform a semi-structured movement protocol to investigate the ability of the Actigraph GT3X accelerometer to identify body position (lying, sitting or standing) and quantify step count.

Primary outcomes

  1. Ability of an Accelerometer to Identify Step Count

    Time frame: Participants wore the accelerometers for a maximum of 3 hours, undertaking a semi-structured movement protocol

    Agreement between direct observation and the activity monitors (ankle and thigh placements in isolation) in determination of step count. The mean difference (95% Limits of Agreement) between observed step count and accelerometer quantified step count for the same walk were calculated. Negative values reflected an underestimation of observed step count by the accelerometer and positive values reflected an overestimation of step count.

Secondary outcomes

  1. Comfort of Accelerometers

    Time frame: Accelerometers were worn for a period not exceeding 3 hours

    Participants were asked to rate their assessment of how comfortable the accelerometers were. They were requested to choose a statement on a five-point Likert Scale. The statements were:

    • Very uncomfortable
    • Somewhat uncomfortable
    • Neither comfortable nor uncomfortable
    • Somewhat comfortable
    • Very comfortable

    Participants chose the most appropriate statement which they felt reflected how comfortable they found the accelerometers to wear.

Sponsors and collaborators

Lead sponsor

Hull University Teaching Hospitals NHS Trust

Other Gov

Registry information

Official study title

Criterion Validity of the Actigraph GT3X Accelerometer in Determination of Body Position and Walking in Hospital Ward Patients Recovering From Critical Illness

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Sep 28, 2017
Registry last updated
Oct 7, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.